It is administered over 10-20 minutes and can help to treat a variety of diseases such as immune-mediated diseases, infection, allergies, cancer, chronic fatigue, etc
The rise in popularity over a short period of time also brought product liability lawsuits against the manufacturers claiming injury with one source showing 1,997 lawsuits as of July 4 with the primary concern being gastrointestinal issues and a rising concern of NAION, an eye condition causing loss of vision
FDA Approves Orforglipron, First GLP-1 Pill Without Time, Food, or Water Restrictions
Kuerka, N., Tristram-Nagle, S
The single-dose vials and single-dose pens are not
If you want to understand how prescription GLP-1 care starts, our free assessment quiz is the natural first step